Clinical Trial to Reduce Drinking in Women With HIV

PHASE3CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
HIV Infection
Interventions
DRUG

Naltrexone

The study involves taking the drug naltrexone for up to 4 months. This will be given in a single pill each day for 4 months.

DRUG

Placebo

Placebo is an inert pill that looks the same as naltrexone. The placebo will be taken once each day for up to 4 months.

Trial Locations (2)

33124

University of Miami, Coral Gables

33199

Florida International University, Miami

All Listed Sponsors
collaborator

Florida International University

OTHER

collaborator

University of Miami

OTHER

collaborator

Rush University

OTHER

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Florida

OTHER

NCT01625091 - Clinical Trial to Reduce Drinking in Women With HIV | Biotech Hunter | Biotech Hunter